$MRK Recent News Here are the best-performing stocks so

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2015 at 12:34 PM

$MRK Recent News

Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore

Ebola Vaccines Ready for West Africa Tests This Month, Says WHO 11:05 a.m. Jan. 9, 2015 - The Wall Street Journal Interactive Edition
The Bullish and Bearish Case for Pfizer in 2015 10:37 a.m. Jan. 9, 2015 - 247WallSt.com
Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014 9:25 a.m. Jan. 9, 2015 - GuruFocus.com
FDA clears Daiichi-Sankyo anticoagulant 7:55 p.m. Jan. 8, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 1:00 p.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Merck in 2015 10:44 a.m. Jan. 8, 2015 - 247WallSt.com
Trade-Ideas: Merck (MRK) Is Today's Momo Momentum Stock 9:49 a.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Johnson & Johnson in 2015 7:24 a.m. Jan. 8, 2015 - 247WallSt.com
5 Potential Blockbuster Drugs Set To Launch In 2015 7:02 a.m. Jan. 8, 2015 - Investors Business Daily
Meredith Acquires Selectable Media, Boosts Digital Portfolio - Analyst Blog 4:09 p.m. Jan. 7, 2015 - Zacks.com
The 4 Stocks That Lifted the DJIA on Wednesday 3:17 p.m. Jan. 7, 2015 - 247WallSt.com
CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog 2:16 p.m. Jan. 7, 2015 - Zacks.com
Pfizer: Seems Like The Right Time To Buy 1:51 p.m. Jan. 7, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 12:00 p.m. Jan. 7, 2015 - TheStreet.com
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers 5:39 p.m. Jan. 6, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Higher 2:00 p.m. Jan. 6, 2015 - TheStreet.com
3 Drugs Stocks On The Rise 12:10 p.m. Jan. 6, 2015 - TheStreet.com
5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List 8:10 a.m. Jan. 6, 2015 - 247WallSt.com
Dow Dividend Dogs: Yahoo Finds 2.83% Edge For 5 Lowest Price High Yield January 2 Issues 7:46 a.m. Jan. 6, 2015 - Seeking Alpha

Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Jan. 9, 2015 - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Explosive Growth: Wellness Economy Now A $7.5T Force

A Surge in Global Wellness How about this for a shakeup? The global wellness economy isn't just surviving; it's roaring. Clocking in at a staggering $7.5 trillion in 2025, it's set on a straight trajectory to $10.9 trillion by 2030. Talk about making waves! This isn't just some passing fad; it's where money's being funneled fast, and for good reason. Why the Boom? Ever...

ACR Poker's $20M Series Sparks Player Excitement

ACR Poker Lights Up the Felt Again Jump into the buzz, folks—ACR Poker's gone all-in with a whopping $20 million guaranteed Online Super Series (OSS). Now, they're no strangers to the high stakes and the whirlwind of adrenaline that comes with it. From November 8th to 24th, the action's hotter than the sun in Costa Rica, and every player wants a piece of the pie. Turbo...

Michaels' Countdown to Craftsmas: Screen-Free Holiday Offer

Crafting Memories over Clicking Screens The holidays are supposed to be about making memories, right? Well, Michaels is banking on that idea by pulling people away from their screens and nudging them into a hands-on world with its "Countdown to Craftsmas" advent calendar. Starting November 27, they’re tossing in a freebie that’s packing some crafty punches — just...

Innovative Storm Protection System for New Homes Unveiled

A Fresh Approach to Storm Preparedness Natural disasters don't give you the luxury of foresight—they just roll in uninvited, leaving chaos in their wake. Now, here's a tale of someone who's taken matters into his own hands. This tinkerer from Los Angeles scratched his head long enough and came up with what he's calling the 'MENDEZ INVENTION.' A contrivance aimed at...

Advantech's SOM-5994: Transforming Edge Networking

Breaking Down the Advantech SOM-5994 Module Advantech is at it again, folks! This time, they're bolstering edge networking capabilities with their new SOM-5994 module, powered by Intel Atom P6900 processors. This breakthrough is not just a run-of-the-mill tech upgrade—it's a strategic step toward reshaping the networking landscape. A Power-Packed Processor for Modern...

Gilat's Revenue Dip Spurs Legal Scrutiny for Investors

Gilat Satellite's Surprise Revenue Shortfall If anybody thought the satellite business was all about science fiction-esque technology, here's a reality check: when earnings don't meet expectations, shareholders get jittery. This seems to be exactly what's happening with Gilat Satellite Networks Ltd. (NASDAQ: GILT). After twice reaffirming their fiscal 2026 revenue...

Valens Semiconductor Shows Strong Q3 2026 Performance

Valens Semiconductor Surpasses Revenue Expectations Here's the scoop: Valens Semiconductor (NYSE: VLN) just blew past their Q3 2026 revenue guidance with a solid $21.9 million, marking a high point in CEO Yoram Salinger's first year at the helm. Sure, they booked a net loss of $5.5 million, but let's face it, these results show a healthy trajectory, especially if you look...

Oracle's Opower Drives Record Utility Success in 2026

Peak Performance: Oracle Opower's Latest Surge Hey, energy watchers, if you don't have Oracle Opower on your radar, it might be time for a check-up! These folks have achieved more peak energy demand reduction this year than you've seen in quite some time. We're talking 1 gigawatt reduced across 70-plus events, no less. Wrap your head around that for a minute! That's like...

McEwen Faces Investigation Amid Declining Production

MUX Investors on Alert as Legal Stakes Rise The gold mining world isn't exactly flooded with excitement these days, and McEwen Inc.'s (NYSE: MUX) latest dealings ain't doing much to brighten up the scenery. When their third-quarter gold output took a nosedive—a 23% drop to be exact—it caught more eyes than a bull market will. Production Guidance in Question Now,...

Shanghai Biennale: LOUDER Brings Culture to Forefront

Shanghai and the Cultural Pulse of 2027 The 16th Shanghai Biennale is making some noise, and it's got a fitting title to match: LOUDER. Set to take the stage in November 2027, hosted by the Power Station of Art and curated by Ferran Barenblit, it's all about the soundtrack and visual kaleidoscope of our lives—a reminder that we're not just consumers of culture but...